4th Austrian pancreas day: a summary of the surgical management of exocrine pancreatic neoplasms View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-09-11

AUTHORS

K. Sahora, M. Schindl, M. Gnant

ABSTRACT

BackgroundIn the twenty-first century management of pancreatic diseases remains a challenge for surgeons, gastroenterologists, anesthesiologists, pathologists, radiologists, and oncologists. While the techniques of pancreatic resections have not changed within the last decades, nowadays multimodal neoadjuvant treatment strategies offer curative surgical therapy to a higher percentage of patients. Furthermore, new knowledge has emerged about the biology and treatment of cystic lesions of the pancreas.MethodsWe summarized the surgical topics of the upcoming meeting entitled “4th Austrian Pancreas Day”.ResultsEven after decades of intense research the ductal adenocarcinoma of the pancreas stays a deadly disease. A curative R0 resection remains the only treatment potentially prolonging overall survival. Esposito et al. as well as Verbeke et al. demonstrated that axial slicing and extensive tissue sampling, raises the R1 resection rate up to 85 %, compared to R1 rates of 10–20 % in older series with basic pathological workup. In locally and advanced and borderline resectable pancreatic cancer, novel chemotherapeutic regimes like Folfirinox in combination with or without radiotherapy proved to offer satisfying response rates, making curative resection feasible in more patients. At the same time, the number of patients incidentally diagnosed with cystic lesion of the pancreas is continuously rising. However, only some of these patients need pancreatic surgery while others can be safely observed. In 2012 the International Association of Pancreatology has revised their guidelines for the management of mucinous cystic neoplasms and intraductal papillary mucinous neoplasms, deemphasizing cyst size as a worrisome feature.ConclusionsToday, patients with pancreatic neoplasms need to be managed by an experienced interdisciplinary team. In such professional setting it should by our goal to curatively resect as much as possible patients with pancreatic malignancies and at the same time reduce the number of unnecessary operations of benign cystic neoplasms. More... »

PAGES

277-281

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10353-013-0229-5

DOI

http://dx.doi.org/10.1007/s10353-013-0229-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1013875251


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18\u201320, 1190, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18\u201320, 1190, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sahora", 
        "givenName": "K.", 
        "id": "sg:person.01346566072.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346566072.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18\u201320, 1190, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18\u201320, 1190, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schindl", 
        "givenName": "M.", 
        "id": "sg:person.0603017413.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603017413.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18\u201320, 1190, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18\u201320, 1190, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gnant", 
        "givenName": "M.", 
        "id": "sg:person.01112754113.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112754113.07"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6603719", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019012220", 
          "https://doi.org/10.1038/sj.bjc.6603719"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s005340200101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025039999", 
          "https://doi.org/10.1007/s005340200101"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-09-11", 
    "datePublishedReg": "2013-09-11", 
    "description": "BackgroundIn the twenty-first century management of pancreatic diseases remains a challenge for surgeons, gastroenterologists, anesthesiologists, pathologists, radiologists, and oncologists. While the techniques of pancreatic resections have not changed within the last decades, nowadays multimodal neoadjuvant treatment strategies offer curative surgical therapy to a higher percentage of patients. Furthermore, new knowledge has emerged about the biology and treatment of cystic lesions of the pancreas.MethodsWe summarized the surgical topics of the upcoming meeting entitled \u201c4th Austrian Pancreas Day\u201d.ResultsEven after decades of intense research the ductal adenocarcinoma of the pancreas stays a deadly disease. A curative R0 resection remains the only treatment potentially prolonging overall survival. Esposito et al. as well as Verbeke et al. demonstrated that axial slicing and extensive tissue sampling, raises the R1 resection rate up to 85\u00a0%, compared to R1 rates of 10\u201320\u00a0% in older series with basic pathological workup. In locally and advanced and borderline resectable pancreatic cancer, novel chemotherapeutic regimes like Folfirinox in combination with or without radiotherapy proved to offer satisfying response rates, making curative resection feasible in more patients. At the same time, the number of patients incidentally diagnosed with cystic lesion of the pancreas is continuously rising. However, only some of these patients need pancreatic surgery while others can be safely observed. In 2012 the International Association of Pancreatology has revised their guidelines for the management of mucinous cystic neoplasms and intraductal papillary mucinous neoplasms, deemphasizing cyst size as a worrisome feature.ConclusionsToday, patients with pancreatic neoplasms need to be managed by an experienced interdisciplinary team. In such professional setting it should by our goal to curatively resect as much as possible patients with pancreatic malignancies and at the same time reduce the number of unnecessary operations of benign cystic neoplasms.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10353-013-0229-5", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1371289", 
        "issn": [
          "1682-8631", 
          "1682-4016"
        ], 
        "name": "European Surgery", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "45"
      }
    ], 
    "keywords": [
      "cystic lesions", 
      "cystic neoplasms", 
      "pancreatic neoplasms", 
      "borderline resectable pancreatic cancer", 
      "intraductal papillary mucinous neoplasm", 
      "neoadjuvant treatment strategies", 
      "curative surgical therapy", 
      "curative R0 resection", 
      "R1 resection rate", 
      "experienced interdisciplinary team", 
      "resectable pancreatic cancer", 
      "mucinous cystic neoplasm", 
      "number of patients", 
      "papillary mucinous neoplasm", 
      "benign cystic neoplasm", 
      "exocrine pancreatic neoplasms", 
      "extensive tissue sampling", 
      "R0 resection", 
      "curative resection", 
      "pancreatic resection", 
      "surgical therapy", 
      "overall survival", 
      "resection rate", 
      "more patients", 
      "pathological workup", 
      "pancreatic surgery", 
      "worrisome features", 
      "surgical management", 
      "mucinous neoplasms", 
      "pancreatic malignancy", 
      "pancreatic cancer", 
      "ductal adenocarcinoma", 
      "treatment strategies", 
      "cyst size", 
      "possible patients", 
      "pancreatic disease", 
      "chemotherapeutic regimes", 
      "R1 rate", 
      "patients", 
      "response rate", 
      "neoplasms", 
      "only treatment", 
      "resection", 
      "tissue sampling", 
      "deadly disease", 
      "pancreas", 
      "surgical topics", 
      "axial slicing", 
      "unnecessary operations", 
      "lesions", 
      "interdisciplinary team", 
      "disease", 
      "high percentage", 
      "treatment", 
      "days", 
      "older series", 
      "FOLFIRINOX", 
      "International Association", 
      "gastroenterologists", 
      "adenocarcinoma", 
      "surgery", 
      "malignancy", 
      "oncologists", 
      "radiotherapy", 
      "therapy", 
      "management", 
      "anesthesiologists", 
      "workup", 
      "cancer", 
      "MethodsWe", 
      "surgeons", 
      "Pancreatology", 
      "pathologists", 
      "survival", 
      "radiologists", 
      "rate", 
      "ConclusionsToday", 
      "ResultsEven", 
      "intense research", 
      "BackgroundIn", 
      "association", 
      "guidelines", 
      "century management", 
      "percentage", 
      "setting", 
      "last decade", 
      "summary", 
      "number", 
      "team", 
      "time", 
      "decades", 
      "meeting", 
      "new knowledge", 
      "combination", 
      "same time", 
      "strategies", 
      "biology", 
      "knowledge", 
      "sampling", 
      "series", 
      "features", 
      "challenges", 
      "professional settings", 
      "goal", 
      "research", 
      "technique", 
      "size", 
      "et al", 
      "operation", 
      "topic", 
      "upcoming meeting", 
      "al", 
      "slicing", 
      "regime"
    ], 
    "name": "4th Austrian pancreas day: a summary of the surgical management of exocrine pancreatic neoplasms", 
    "pagination": "277-281", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1013875251"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10353-013-0229-5"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10353-013-0229-5", 
      "https://app.dimensions.ai/details/publication/pub.1013875251"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_588.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10353-013-0229-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10353-013-0229-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10353-013-0229-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10353-013-0229-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10353-013-0229-5'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      22 PREDICATES      141 URIs      131 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10353-013-0229-5 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N0c832dfb484d4dcb961a02759809559f
4 schema:citation sg:pub.10.1007/s005340200101
5 sg:pub.10.1038/sj.bjc.6603719
6 schema:datePublished 2013-09-11
7 schema:datePublishedReg 2013-09-11
8 schema:description BackgroundIn the twenty-first century management of pancreatic diseases remains a challenge for surgeons, gastroenterologists, anesthesiologists, pathologists, radiologists, and oncologists. While the techniques of pancreatic resections have not changed within the last decades, nowadays multimodal neoadjuvant treatment strategies offer curative surgical therapy to a higher percentage of patients. Furthermore, new knowledge has emerged about the biology and treatment of cystic lesions of the pancreas.MethodsWe summarized the surgical topics of the upcoming meeting entitled “4th Austrian Pancreas Day”.ResultsEven after decades of intense research the ductal adenocarcinoma of the pancreas stays a deadly disease. A curative R0 resection remains the only treatment potentially prolonging overall survival. Esposito et al. as well as Verbeke et al. demonstrated that axial slicing and extensive tissue sampling, raises the R1 resection rate up to 85 %, compared to R1 rates of 10–20 % in older series with basic pathological workup. In locally and advanced and borderline resectable pancreatic cancer, novel chemotherapeutic regimes like Folfirinox in combination with or without radiotherapy proved to offer satisfying response rates, making curative resection feasible in more patients. At the same time, the number of patients incidentally diagnosed with cystic lesion of the pancreas is continuously rising. However, only some of these patients need pancreatic surgery while others can be safely observed. In 2012 the International Association of Pancreatology has revised their guidelines for the management of mucinous cystic neoplasms and intraductal papillary mucinous neoplasms, deemphasizing cyst size as a worrisome feature.ConclusionsToday, patients with pancreatic neoplasms need to be managed by an experienced interdisciplinary team. In such professional setting it should by our goal to curatively resect as much as possible patients with pancreatic malignancies and at the same time reduce the number of unnecessary operations of benign cystic neoplasms.
9 schema:genre article
10 schema:inLanguage en
11 schema:isAccessibleForFree false
12 schema:isPartOf N3722a05e9caa4c69ae7d1f92b6428ebe
13 N4e1138da4e6946d9a0e7ff8e5c6f52b4
14 sg:journal.1371289
15 schema:keywords BackgroundIn
16 ConclusionsToday
17 FOLFIRINOX
18 International Association
19 MethodsWe
20 Pancreatology
21 R0 resection
22 R1 rate
23 R1 resection rate
24 ResultsEven
25 adenocarcinoma
26 al
27 anesthesiologists
28 association
29 axial slicing
30 benign cystic neoplasm
31 biology
32 borderline resectable pancreatic cancer
33 cancer
34 century management
35 challenges
36 chemotherapeutic regimes
37 combination
38 curative R0 resection
39 curative resection
40 curative surgical therapy
41 cyst size
42 cystic lesions
43 cystic neoplasms
44 days
45 deadly disease
46 decades
47 disease
48 ductal adenocarcinoma
49 et al
50 exocrine pancreatic neoplasms
51 experienced interdisciplinary team
52 extensive tissue sampling
53 features
54 gastroenterologists
55 goal
56 guidelines
57 high percentage
58 intense research
59 interdisciplinary team
60 intraductal papillary mucinous neoplasm
61 knowledge
62 last decade
63 lesions
64 malignancy
65 management
66 meeting
67 more patients
68 mucinous cystic neoplasm
69 mucinous neoplasms
70 neoadjuvant treatment strategies
71 neoplasms
72 new knowledge
73 number
74 number of patients
75 older series
76 oncologists
77 only treatment
78 operation
79 overall survival
80 pancreas
81 pancreatic cancer
82 pancreatic disease
83 pancreatic malignancy
84 pancreatic neoplasms
85 pancreatic resection
86 pancreatic surgery
87 papillary mucinous neoplasm
88 pathological workup
89 pathologists
90 patients
91 percentage
92 possible patients
93 professional settings
94 radiologists
95 radiotherapy
96 rate
97 regime
98 research
99 resectable pancreatic cancer
100 resection
101 resection rate
102 response rate
103 same time
104 sampling
105 series
106 setting
107 size
108 slicing
109 strategies
110 summary
111 surgeons
112 surgery
113 surgical management
114 surgical therapy
115 surgical topics
116 survival
117 team
118 technique
119 therapy
120 time
121 tissue sampling
122 topic
123 treatment
124 treatment strategies
125 unnecessary operations
126 upcoming meeting
127 workup
128 worrisome features
129 schema:name 4th Austrian pancreas day: a summary of the surgical management of exocrine pancreatic neoplasms
130 schema:pagination 277-281
131 schema:productId N153209b445244a6286f95bca8cc1eb78
132 Ne0e7fb4234584b8eb5d2f421bca2972a
133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013875251
134 https://doi.org/10.1007/s10353-013-0229-5
135 schema:sdDatePublished 2022-05-20T07:28
136 schema:sdLicense https://scigraph.springernature.com/explorer/license/
137 schema:sdPublisher Nf111eac823094fe2976f8e562e7bfa3b
138 schema:url https://doi.org/10.1007/s10353-013-0229-5
139 sgo:license sg:explorer/license/
140 sgo:sdDataset articles
141 rdf:type schema:ScholarlyArticle
142 N0c832dfb484d4dcb961a02759809559f rdf:first sg:person.01346566072.85
143 rdf:rest N725341b0db6b4dd19a5275c4be0a33f9
144 N153209b445244a6286f95bca8cc1eb78 schema:name doi
145 schema:value 10.1007/s10353-013-0229-5
146 rdf:type schema:PropertyValue
147 N3722a05e9caa4c69ae7d1f92b6428ebe schema:volumeNumber 45
148 rdf:type schema:PublicationVolume
149 N4e1138da4e6946d9a0e7ff8e5c6f52b4 schema:issueNumber 5
150 rdf:type schema:PublicationIssue
151 N632f51631c86480c8c73f35f48bb85a7 rdf:first sg:person.01112754113.07
152 rdf:rest rdf:nil
153 N725341b0db6b4dd19a5275c4be0a33f9 rdf:first sg:person.0603017413.32
154 rdf:rest N632f51631c86480c8c73f35f48bb85a7
155 Ne0e7fb4234584b8eb5d2f421bca2972a schema:name dimensions_id
156 schema:value pub.1013875251
157 rdf:type schema:PropertyValue
158 Nf111eac823094fe2976f8e562e7bfa3b schema:name Springer Nature - SN SciGraph project
159 rdf:type schema:Organization
160 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
161 schema:name Medical and Health Sciences
162 rdf:type schema:DefinedTerm
163 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
164 schema:name Oncology and Carcinogenesis
165 rdf:type schema:DefinedTerm
166 sg:journal.1371289 schema:issn 1682-4016
167 1682-8631
168 schema:name European Surgery
169 schema:publisher Springer Nature
170 rdf:type schema:Periodical
171 sg:person.01112754113.07 schema:affiliation grid-institutes:grid.22937.3d
172 schema:familyName Gnant
173 schema:givenName M.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112754113.07
175 rdf:type schema:Person
176 sg:person.01346566072.85 schema:affiliation grid-institutes:grid.22937.3d
177 schema:familyName Sahora
178 schema:givenName K.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346566072.85
180 rdf:type schema:Person
181 sg:person.0603017413.32 schema:affiliation grid-institutes:grid.22937.3d
182 schema:familyName Schindl
183 schema:givenName M.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603017413.32
185 rdf:type schema:Person
186 sg:pub.10.1007/s005340200101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025039999
187 https://doi.org/10.1007/s005340200101
188 rdf:type schema:CreativeWork
189 sg:pub.10.1038/sj.bjc.6603719 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019012220
190 https://doi.org/10.1038/sj.bjc.6603719
191 rdf:type schema:CreativeWork
192 grid-institutes:grid.22937.3d schema:alternateName Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18–20, 1190, Vienna, Austria
193 schema:name Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18–20, 1190, Vienna, Austria
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...